AKT1 and non-small cell lung carcinoma: Consistently, we observed increased phosphorylated PI3K and AKT in FN-treated A549 and Lewis cells at the protein level by western blotting (Fig. 3A), suggesting the activation of the PI3K/AKT signaling pathway in NSCLC cells treated with FN.